Epidemiology and Economy, and the Appraisal of Human Life: Ethical and Practical Limitations of how to Value Health Benefits

  • U. Laaser


Money is considered to be a hard value, but this is not so with life! According to our ethical codex, the value of life is expected to be equally high under all circumstances. Nevertheless, money is different insofar as purchasing power and even the exchange rates vary almost from day to day.


Exchange Rate Project Research Group Pooling Project Large Intervention Trial Society Priority 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1).
    Nissinen A.; Tuomilehto J.; Kottke Th.E.; Puska P. (1986) Cost- effectiveness of the North Karelia Hypertension Program: 1972–1977. Medical Care 24 /8: 767–780PubMedCrossRefGoogle Scholar
  2. (2).
    Acton J.P. (1975) Measuring the social impact of heart and circulatory disease programs, RAND R-1697Google Scholar
  3. (3).
    Kriedel Th. (1980) Effizienzanalysen im Gesundheitswesen, Springer, BerlinGoogle Scholar
  4. (4).
    Thompson M.S. (1986) Willingness to pay and accept risks to cure chronic disease, AJPH, Vol. 76, No. 4: 392–396CrossRefGoogle Scholar
  5. (5).
    Böhm P. (1972) Estimating demand for public goods: an experiment, Europ. Economic Review 3: 111–130Google Scholar
  6. (6).
    Hoffmeister H.; Stolzenberg H.; Schön D. etal. (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP. Bd. II. DHP Forum Berichte und MitteilungenGoogle Scholar
  7. (7).
    The Pooling Project Research Group (1978) Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report. J. Chron. Dis. 31: 201ffCrossRefGoogle Scholar
  8. (8).
    Laaser U.; Allhoff P. (1986) Cardiovascular intervention studies: problems and perspectives, in: Kaufmann W. etal. (eds.) Primary hypertension. Springer, Berlin S. 145–152Google Scholar
  9. (9).
    Torrance G.W. (1984) Health states worse than death, in: van Eimeren W, Engelbrecht R., Flagle Ch.D. (eds.), 3rd Int. Conference on Systems in Health Care. Springer, BerlinGoogle Scholar
  10. (10).
    Rosser, R.; Kind, P. (1978) A scale of valuations of states of illness: is there a social consensus ? Int. J. Epidem. 7: 347–358CrossRefGoogle Scholar
  11. (11).
    Wenzel H.; Laaser U. (1190) Kosten-Wirksamkeit der Raucherentwönhnung mit Hilfe von Nikotin-Kaugummi. Z. Präventivmed. Gesundheitsförd.2/1 (im Druck)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • U. Laaser

There are no affiliations available

Personalised recommendations